Skip to content

Brain Stimulation with Light for Chronic Migraine

Photobiomodulation by Transcranial Infrared Light Stimulation (FBM) in Chronic Common Migraine (CCM)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-857zyyw
Enrollment
Unknown
Registered
2026-01-07
Start date
2024-03-23
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine without aura

Interventions

This study is a randomized, prospective, two-arm, blinded clinical trial comparing the efficacy and tolerability of transcranial photobiomodulation (t-PBM) versus sham stimulation (control group) in r
all participants signed the Informed Consent Form, guaranteeing confidentiality and use of data exclusively for scientific purposes. There was no financial burden on the participants. The sample consi

Sponsors

Município Do Cabo de Santo Agostinho
Lead Sponsor
Município Do Cabo de Santo Agostinho
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Volunteers of both sexes aged between 18 and 90 years; with more than 15 migraine days per month; using migraine prophylaxis medication in the last three months

Exclusion criteria

Exclusion criteria: Patients under 18 years of age; pregnant women; epileptics; patients with sequelae of acute or subacute stroke; patients who abuse analgesic medications for headaches; patients with catamenial headache; patients with less than 15 days of pain per month

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: A reduction in the number of days with pain is expected 30 days after the intervention is completed, adjusted for baseline;Outcome finding 1 showed a significant reduction to 9.78 ± 7.12 days per month compared to the baseline of 16 days of pain per month (median 7.00), representing an absolute decrease of 6.22 days and a percentage reduction of 38.9%. Data were collected 30 days after the completion of treatment through the completion of a migraine diary

Secondary

MeasureTime frame
Secondary outcome a positive impact on the quality of life of patients treated with photobiomodulation was observed; this improvement was seen in both the active and control groups, with a trend towards superiority in the active group, as assessed by the SF-36 (Short Form Health Questionnaire) with 36 items

Countries

Brazil

Contacts

Public ContactIdele Cantalice

Município Do Cabo de Santo Agostinho

idelegcantalice@hotmail.com+55(81)3201-3400

Outcome results

None listed

Source: REBEC (via WHO ICTRP)